Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Depreciation & Amortization (CF): 2017-2024

Historic Depreciation & Amortization (CF) for Solid Biosciences (SLDB) over the last 8 years, with Dec 2024 value amounting to $488,000.

  • Solid Biosciences' Depreciation & Amortization (CF) fell 16.87% to $488,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.5 million, marking a year-over-year decrease of 4.88%. This contributed to the annual value of $2.5 million for FY2024, which is 4.88% down from last year.
  • According to the latest figures from Q4 2024, Solid Biosciences' Depreciation & Amortization (CF) is $488,000, which was up 20.49% from $405,000 recorded in Q3 2024.
  • In the past 5 years, Solid Biosciences' Depreciation & Amortization (CF) ranged from a high of $1.3 million in Q2 2020 and a low of $327,000 during Q1 2024.
  • Its 3-year average for Depreciation & Amortization (CF) is $620,333, with a median of $587,500 in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 102.74% in 2020, then crashed by 53.49% in 2024.
  • Over the past 5 years, Solid Biosciences' Depreciation & Amortization (CF) (Quarterly) stood at $796,000 in 2020, then decreased by 4.52% to $760,000 in 2021, then declined by 29.08% to $539,000 in 2022, then rose by 8.91% to $587,000 in 2023, then fell by 16.87% to $488,000 in 2024.
  • Its Depreciation & Amortization (CF) was $488,000 in Q4 2024, compared to $405,000 in Q3 2024 and $1.2 million in Q2 2024.